Host: Peter Buch, MD, FACG, AGAF, FACP
Guest: Adam S. Cheifetz, MD
Guest: Adam S. Cheifetz, MD
Therapeutic drug monitoring has emerged as an important tool to optimize therapy for patients with inflammatory bowel disease (IBD). To help us learn more about this tool, Dr. Peter Buch is joined by Dr. Adam Cheifetz of Beth Israel Deaconess Medical Center and Professor of Medicine at Harvard Medical School.
05/19/22 • 0 min
Generate a badge
Get a badge for your website that links back to this episode
Select type & size
<a href="https://goodpods.com/podcasts/gi-insights-205123/evaluating-therapeutic-drug-monitoring-in-ibd-21163618"> <img src="https://storage.googleapis.com/goodpods-images-bucket/badges/generic-badge-1.svg" alt="listen to evaluating therapeutic drug monitoring in ibd on goodpods" style="width: 225px" /> </a>
Copy